Outcomes of hypofractionated stereotactic body radiotherapy boost for intermediate and high-risk prostate cancer.

Home / Publications / Outcomes of hypofractionated stereotactic body radiotherapy boost for intermediate and high-risk prostate cancer.
Radiation oncology (London, England)

Anwar M, Weinberg V, Seymour Z, Hsu IJ, Roach M, Gottschalk AR. Outcomes of hypofractionated stereotactic body radiotherapy boost for intermediate and high-risk prostate cancer. Radiat Oncol. 2016 Jan 21; 11:8.

2016
https://researcherprofiles.org/profile/1197907
26792201

Anwar M, Weinberg V, Seymour Z, Hsu IJ, Roach M, Gottschalk AR

Support Engineering Innovations at UCSF

Donate